ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jack A. Roth
Harvey I. Pass
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perry, R. R.
Right arrow Articles by Pass, H. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perry, R. R.
Right arrow Articles by Pass, H. I.

Ann Thorac Surg 1990;49:363-369
© 1990 The Society of Thoracic Surgeons


Articles

Survival after surgical resection for high-grade chest wall sarcomas

Roger R. Perry, MD*, David Venzon, PhD, Jack A. Roth, MD, Harvey I. Pass, MD*

Surgery Branch and Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

* Address reprint requests to Dr Pass, Thoracic Oncology Section, Surgery Branch, National Cancer Institute/NIH, Bldg 10, Room 2B07, Bethesda, MD 20892.

Indications for chest wall resection of metastatic or locally recurrent sarcoma and for subsequent bony reconstruction are controversial. Twenty-eight patients had chest wall resection for high-grade primary, metastatic, or recurrent sarcoma. In all patients, resection with selective reconstruction of the bony thorax was performed without operative mortality. Since 1980, only patients with four or more ribs resected have had selective bony reconstruction. Follow-up ranged from 8 to 132 months (median follow-up, 42 months). All deaths were related to sarcoma recurrence. The overall actuarial survival rate was 85% at 1 year, 65% at 3 years, and 59% at more than 5 years. The overall actuarial proportion without disease recurrence was 64% at 1 year, 52% at 3 years, and 40% at more than 5 years. There was no significant difference in overall or disease-free survival for patients with primary, metastatic, or recurrent tumors. The most important prognostic factors were positive margins and concomitant pulmonary resection for synchronous lung metastases. These data support aggressive resection to obtain pathologically tumor-free margins for chest wall sarcomas, whether primary, metastatic, or recurrent. Reconstruction can be individualized based on the extent of resection.




This article has been cited by other articles:


Home page
Eur J Cardiothorac SurgHome page
S.-H. Hemmati, A. M. Correa, G. L. Walsh, S. G. Swisher, J. A. Roth, D. C. Rice, R. J. Mehran, and A. A. Vaporciyan
The prognostic factors of chest wall metastasis resection
Eur J Cardiothorac Surg, August 1, 2011; 40(2): 328 - 333.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
D. Heuker, B. Lengele, V. Delecluse, B. Weynand, G. Liistro, B. Balduyck, P. Noirhomme, and A. J. Poncelet
Subjective and objective assessment of quality of life after chest wall resection
Eur J Cardiothorac Surg, January 1, 2011; 39(1): 102 - 108.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. W. Wouters, A. N. van Geel, L. Nieuwenhuis, H. van Tinteren, C. Verhoef, F. van Coevorden, and H. M. Klomp
Outcome After Surgical Resections of Recurrent Chest Wall Sarcomas
J. Clin. Oncol., November 1, 2008; 26(31): 5113 - 5118.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. L. Walsh, B. M. Davis, S. G. Swisher, A. A. Vaporciyan, W. R. Smythe, K. Willis-Merriman, J. A. Roth, and J. B. Putnam Jr
A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections
J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0048 - 60.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. S. Allen, D. L. Miller, C. Deschamps, V. F. Trastek, and P. C. Pairolero
Chest wall tumors
Ann. Thorac. Surg., March 1, 1999; 67(3): 889 - 890.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Incarbone, M. Nava, C. Lequaglie, G. Ravasi, and U. Pastorino
STERNAL RESECTION FOR PRIMARY OR SECONDARY TUMORS
J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 93 - 99.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
F. Puma, M. Ragusa, and G. Daddi
Chest wall stabilization with synthetic reabsorbable material
Ann. Thorac. Surg., March 1, 1992; 53(3): 408 - 411.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1990 by The Society of Thoracic Surgeons.